• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

15 年内局限性肾细胞癌患者其他原因死亡率的评估:一项基于人群的分析。

Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis.

机构信息

Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.

Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.

出版信息

J Surg Oncol. 2020 Dec;122(7):1506-1513. doi: 10.1002/jso.26149. Epub 2020 Aug 18.

DOI:10.1002/jso.26149
PMID:32812284
Abstract

BACKGROUND AND OBJECTIVE

Five-year other cause mortality (OCM) after nephrectomy for non-metastatic renal cell carcinoma (RCC) should be marginal in properly selected surgical candidates. We examined 5-year OCM rates as a quality of care indicator for patient selection.

MATERIALS AND METHODS

Within the Surveillance, Epidemiology, and End Results database (1997-2011), we identified 59267 RCC patients treated with either radical (n = 27 804, 46.9%) or partial nephrectomy (n = 31 463, 53.1%). Temporal trends and multivariable Cox regression analyses assessed 5-year OCM. Data were stratified according to age group, year of diagnosis, race, marital status, gender, and socio-economic status. The overall OCM rates for the entire cohort at 5 years of follow-up was 4.7% and decreased from 9.4% to 5.6% over the study span (-3.8%, P < .001). The greatest decrease in 5-year OCM rates over time was recorded in patients >70 years (17.0%-9.6%, slope, -0.6%/y), as well as in African-Americans (12.0-6.2%; slope, -0.3%/y) and in males (8.9%-4.7%; slope, -0.3%, all P < .001).

CONCLUSIONS

An important OCM decrease was recorded over the study span. Nonetheless, further improvement may be accomplished, especially in African-Americans, unmarried and older individuals, who exhibited higher OCM rates than others. These three groups may represent ideal targets for better patient selection based on OCM considerations.

摘要

背景与目的

对于无转移的肾细胞癌(RCC)患者,肾切除术 5 年后的其他原因死亡率(OCM)应在适当选择的手术候选者中处于边缘状态。我们检查了 5 年 OCM 率作为患者选择的护理质量指标。

材料与方法

在监测、流行病学和最终结果数据库(1997-2011 年)中,我们确定了 59267 例接受根治性(n=27804,46.9%)或部分肾切除术(n=31463,53.1%)治疗的 RCC 患者。时间趋势和多变量 Cox 回归分析评估了 5 年 OCM。根据年龄组、诊断年份、种族、婚姻状况、性别和社会经济地位对数据进行分层。整个队列在 5 年随访期间的总 OCM 率为 4.7%,在研究期间从 9.4%降至 5.6%(-3.8%,P<.001)。随着时间的推移,5 年 OCM 率下降幅度最大的是 70 岁以上的患者(17.0%-9.6%,斜率,-0.6%/y),以及非裔美国人(12.0-6.2%;斜率,-0.3%/y)和男性(8.9%-4.7%;斜率,-0.3%,均 P<.001)。

结论

在研究期间,OCM 有显著下降。尽管如此,可能还需要进一步改进,尤其是在非裔美国人、未婚和年龄较大的人群中,这些人群的 OCM 率高于其他人群。这三组人群可能代表着基于 OCM 考虑进行更好的患者选择的理想目标。

相似文献

1
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis.15 年内局限性肾细胞癌患者其他原因死亡率的评估:一项基于人群的分析。
J Surg Oncol. 2020 Dec;122(7):1506-1513. doi: 10.1002/jso.26149. Epub 2020 Aug 18.
2
A non-cancer-related survival benefit is associated with partial nephrectomy.部分肾切除术与非癌症相关的生存获益相关。
Eur Urol. 2012 Apr;61(4):725-31. doi: 10.1016/j.eururo.2011.11.047. Epub 2011 Dec 3.
3
Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.比较部分肾切除术与根治性肾切除术对 75 岁以上患者其他原因死亡率、癌症特异性死亡率和 30 天死亡率的影响。
Eur Urol Focus. 2019 May;5(3):467-473. doi: 10.1016/j.euf.2018.01.007. Epub 2018 Feb 3.
4
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.基于人群的肾细胞癌肾切除术后生存的竞争风险分析。
Urol Oncol. 2014 Jan;32(1):46.e1-7. doi: 10.1016/j.urolonc.2013.06.010. Epub 2013 Sep 17.
5
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.基于人群的 T1A 期肾细胞癌行根治性肾切除术与部分肾切除术的肿瘤控制率比较。
Urology. 2010 Oct;76(4):883-8. doi: 10.1016/j.urology.2009.08.028.
6
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.25 年局部前列腺癌其他原因死亡率的分析。
Clin Genitourin Cancer. 2019 Oct;17(5):395-401. doi: 10.1016/j.clgc.2019.07.008. Epub 2019 Jul 19.
7
Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades.根治性膀胱切除术(radical cystectomy)后其他原因死亡率呈下降趋势——一项基于人群的二十年分析。
J Surg Oncol. 2020 Jun;121(8):1329-1336. doi: 10.1002/jso.25919. Epub 2020 Apr 4.
8
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.对于转移性肾细胞癌,与根治性肾切除术相比,部分肾切除术似乎能带来生存益处。
Cancer Epidemiol. 2018 Oct;56:118-125. doi: 10.1016/j.canep.2018.08.006. Epub 2018 Aug 30.
9
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.比较高龄(≥75 岁)且合并多种基础疾病的 T1 期肾细胞癌患者行部分肾切除术与根治性肾切除术对其他原因死亡率的影响。
BJU Int. 2013 Jan;111(1):67-73. doi: 10.1111/j.1464-410X.2012.11254.x. Epub 2012 May 22.
10
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy.根据部分与根治性细胞减瘤性肾切除术的差异对透明细胞转移性肾细胞癌的生存率进行分析。
Clin Genitourin Cancer. 2024 Feb;22(1):1-6. doi: 10.1016/j.clgc.2023.06.003. Epub 2023 Jun 12.